Resolaris (resokine) / aTyr Pharma - LARVOL DELTA

Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Patients With Muscular Dystrophy (clinicaltrials.gov) - P1/2; N=20; Completed; Sponsor: aTyr Pharma, Inc.; Active, not recruiting ➔ Completed; N=44 ➔ 20; Trial primary completion date: Sep 2017 ➔ Dec 2015

Enrollment change • Trial completion • Trial primary completion date • Biosimilar